Lv41
420 积分 2023-08-28 加入
High‐risk screening for late‐onset Pompe disease in China: An expanded multicenter study
5天前
已完结
Quality assessment of clinical practice guidelines for adult obstructive sleep apnea: A systematic review
13天前
已完结
Residual cardiovascular risk: When should we treat it?
25天前
已完结
Sixty Years of Hemodynamic Pharmacology in Obstructive Hypertrophic Cardiomyopathy
1个月前
已完结
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations
1个月前
已完结
New insights in efficacy of different enzyme replacement therapy dosages in Fabry disease: Switch studies data following agalsidase beta shortage
1个月前
已完结
Hypertrophic cardiomyopathy: investigational drugs inhibiting myosin and upcoming agents
1个月前
已完结
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
2个月前
已完结
Reduced incidence of stroke in patients with Fabry disease treated with agalsidase beta: A matched analysis from the Fabry Registry
2个月前
已完结
Cardiac Myosin Inhibition in Obstructive Hypertrophic Cardiomyopathy
2个月前
已完结
皖公网安备34019202002308
